Stock TPIA MYCOTOPIA THERAPIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Mycotopia Therapies, Inc.

Equities

TPIA

US62846W1071

Delayed OTC Markets
Other stock markets
 12:29:56 2024-06-27 EDT 		5-day change 1st Jan Change
0.03 USD -25.00% Intraday chart for Mycotopia Therapies, Inc. -25.00% +87.50%
05-15 Mycotopia Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-23 Mycotopia Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Managers

Managers TitleAgeSince
Benjamin Kaplan CEO
 Chief Executive Officer 58 21-01-19
David Kugelman IRC
 Investor Relations Contact 59 -

Members of the board

Members of the board TitleAgeSince
Mark Croskery BRD
 Director/Board Member 42 21-01-19
Benjamin Kaplan CEO
 Chief Executive Officer 58 21-01-19

Shareholders

NameEquities%Valuation
Benjamin Kaplan
67.42 %
10,043,754 67.42 % 451 969 $
Mark Williams
6.713 %
999,997 6.713 % 45 000 $
Mark Croskery
0.1135 %
16,912 0.1135 % 761 $

Company contact information

Mycotopia Therapies, Inc.

100 Southeast 2nd Street Suite 2000

33131, Miami

+

address Mycotopia Therapies, Inc.(TPIA)

Sector

This company's sector is not yet available
  1. Stock Market
  2. Equities
  3. TPIA Stock
  4. Company Mycotopia Therapies, Inc.